Inari Medical (NASDAQ:NARI) PT Lowered to $57.00 at Needham & Company LLC
Inari Medical (NASDAQ:NARI – Free Report) had its price objective cut by Needham & Company LLC from $72.00 to $57.00 in a report issued on Wednesday morning, Benzinga reports. They currently have a buy rating on the stock. NARI has been the topic of a number of other reports. Piper Sandler downgraded shares of Inari […]